Many Member States have already announced or have already started to administer COVID-19 vaccine doses additional to the standard primary vaccination series, that is, the vaccination series intended to provide sufficient protection at an initial stage, notably to persons who may not have responded adequately to the primary vaccination series, and are considering ‘booster’ doses for people who responded adequately to primary vaccination. In this context, the European Centre for Disease Prevention and Control published, on 1 September 2021, interim public health considerations for the provision of additional COVID-19 vaccine doses [https://www.ecdc.europa.eu/en/publications-data/covid-19-public-health-considerations-additional-vaccine-doses].
Recital 3, Decision_act (EU) 2021/2014
In forcesince 17 Nov 2021